BEAM - Beam Therapeutics Inc
IEX Last Trade
26.72
-0.120 -0.449%
Share volume: 389,929
Last Updated: Fri 30 Aug 2024 09:59:59 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$26.84
-0.12
-0.45%
View ratios
Fiscal Date | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | |
---|---|---|---|---|---|---|---|---|---|
Fiscal Quarter | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
Report Date | 2022-08-09 | 2022-11-07 | 2023-02-28 | 2023-05-10 | 2023-08-08 | 2023-11-08 | 2024-02-27 | 2024-05-07 | |
Cash flow financing | 22.340 M | 1.562 M | 32.012 M | 98.416 M | 107.542 M | 36.777 M | 33.713 M | 2.897 M | |
Other financing cash flows | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
Cash flow | -52.276 M | -74.496 M | -69.191 M | -109.815 M | -84.669 M | -89.784 M | 135.073 M | -99.747 M | |
Net income | -71.950 M | -109.575 M | -38.349 M | -96.460 M | -82.776 M | -96.088 M | 142.797 M | -98.669 M | |
Depreciation | 3.418 M | 3.473 M | 3.944 M | 4.647 M | 4.816 M | 5.187 M | 5.362 M | 5.431 M | |
Changes in inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
Changes in receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
Investing Cashflow | -1.262 M | -36.174 M | 113.439 M | 25.451 M | -41.480 M | -10.230 M | 98.099 M | -53.464 M | |
Net Borrowings | -1.176 B | -1.105 B | -1.090 B | -1.081 B | -1.093 B | -1.038 B | -1.211 B | -1.122 B | |
Investing Activity Other | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
Dividends Paid | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
Exchange Rate Effect | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
Capital Expenditures | -21.644 M | -11.787 M | -8.261 M | -6.017 M | -16.178 M | -7.948 M | -3.589 M | -2.438 M | |
Cash Change | 1.166 B | 1.095 B | 1.078 B | 1.059 B | 1.073 B | 1.015 B | 1.190 B | 1.095 B |